back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-03 09:42 Tx date 2024-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$22,480
+6,176 vol $3.64 each |
107,270 | |
| Filed 2024-07-05 10:14 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$22,025
+6,459 vol $3.41 each |
101,094 | |
| Filed 2024-04-01 13:59 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$21,808
+5,739 vol $3.80 each |
94,635 | |
| Filed 2024-03-25 13:43 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
88,896 | |
| Filed 2024-01-04 16:01 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,819
+1,265 vol $3.81 each |
39,113 | |
| Filed 2023-12-29 21:34 Tx date 2023-12-29 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+12,439 vol |
33,329 | |
| Filed 2023-10-05 15:02 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,823
+942 vol $5.12 each |
37,848 | |
| Filed 2023-10-05 11:27 Tx date 2023-10-03 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-19,167 vol |
0 | |
| Filed 2023-10-05 11:26 Tx date 2023-10-03 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-99,116.90
-19,246 vol $5.15 each |
0 | |
| Filed 2023-09-03 22:15 Tx date 2023-08-29 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,575
-7,500 vol $0.61 each |
0 | |
| Filed 2023-07-05 15:34 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,858
+842 vol $5.77 each |
36,906 | |
| Filed 2023-06-26 12:37 Tx date 2023-06-23 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,924
+4,905 vol $0.80 each |
7,500 | |
| Filed 2023-04-04 16:24 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,879
+796 vol $6.13 each |
36,064 | |
| Filed 2023-03-05 23:42 Tx date 2023-02-28 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+32,327 vol |
80,812 | |
| Filed 2023-01-04 15:23 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,684
+490 vol $9.56 each |
35,268 | |
| Filed 2023-01-03 20:18 Tx date 2022-12-30 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+7,405 vol |
20,890 | |
| Filed 2022-12-16 16:16 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
34,778 | |
| Filed 2022-12-04 18:45 Tx date 2022-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+21,802 vol |
48,485 | |
| Filed 2022-11-20 11:34 Tx date 2022-11-15 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-88.58
-43 vol $2.06 each |
2,595 | |
| Filed 2022-10-05 16:01 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,583
+515 vol $8.90 each |
14,596 | |
| Filed 2022-10-03 18:59 Tx date 2022-09-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+27,083 vol |
91,204 | |
| Filed 2022-10-03 18:58 Tx date 2022-09-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+7,859 vol |
26,683 | |
| Filed 2022-07-05 15:06 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,550
+364 vol $12.50 each |
14,081 | |
| Filed 2022-06-04 19:08 Tx date 2022-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,192 vol |
64,121 | |
| Filed 2022-06-04 19:08 Tx date 2022-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,514 vol |
18,824 | |
| Filed 2022-05-25 16:18 Tx date 2022-05-25 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,281.92
-5,837 vol $4.16 each |
19,246 | |
| Filed 2022-05-25 16:18 Tx date 2022-05-25 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$79,790
+20,833 vol $3.83 each |
25,083 | |
| Filed 2022-05-25 16:18 Tx date 2022-05-25 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-79,790.39
-20,833 vol $3.83 each |
19,167 | |
| Filed 2022-04-04 09:56 Tx date 2022-03-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,532
+303 vol $14.96 each |
13,717 | |
| Filed 2022-03-07 19:18 Tx date 2022-02-28 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,447 vol |
44,929 | |
| Filed 2022-03-07 19:13 Tx date 2022-02-28 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+2,700 vol |
13,310 | |
| Filed 2022-01-10 16:39 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,530
+300 vol $15.10 each |
13,414 | |
| Filed 2022-01-06 17:01 Tx date 2021-12-31 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+3,948 vol |
13,485 | |
| Filed 2021-12-13 16:52 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,114 | |
| Filed 2021-12-13 16:51 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$4,417
+243 vol $18.18 each |
243 | |
| Filed 2021-12-13 16:49 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-05 11:10 Tx date 2021-12-03 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,800.21
-230 vol $7.83 each |
2,638 | |
| Filed 2021-12-05 11:08 Tx date 2021-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,681 vol |
35,482 | |
| Filed 2021-12-05 11:07 Tx date 2021-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+1,568 vol |
10,610 | |
| Filed 2021-10-03 17:36 Tx date 2021-09-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+1,596 vol |
9,042 | |
| Filed 2021-10-03 17:35 Tx date 2021-09-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,988 vol |
29,801 | |
| Filed 2021-06-24 12:27 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500 | ||
| Filed 2021-06-04 17:24 Tx date 2021-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,820 vol |
23,813 | |
| Filed 2021-06-04 17:23 Tx date 2021-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+1,167 vol |
7,446 | |
| Filed 2021-04-05 10:14 Tx date 2021-03-30 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$51,000
+4,250 vol $12.00 each |
4,250 | |
| Filed 2021-04-01 20:06 Tx date 2021-03-30 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,000
+4,250 vol $12.00 each |
||
| Filed 2021-04-01 20:06 Tx date 2021-03-30 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,000
+4,250 vol $12.00 each |
4,250 | |
| Filed 2021-04-01 20:04 Tx date 2021-03-23 |
$CARE
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-29 13:42 Tx date 2021-03-23 |
$
Dialogue Health Technologies Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2021-03-12 18:41 Tx date 2021-03-11 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+805 vol |
6,279 | |
| Filed 2021-03-05 18:38 Tx date 2021-02-28 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,837 vol |
19,993 | |
| Filed 2021-03-05 18:38 Tx date 2021-02-28 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+975 vol |
5,474 | |
| Filed 2021-01-13 18:41 Tx date 2020-12-31 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+4,816 vol |
9,537 | |
| Filed 2020-12-20 17:06 Tx date 2020-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,371 vol |
17,156 | |
| Filed 2020-12-20 17:05 Tx date 2020-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+860 vol |
4,499 | |
| Filed 2020-09-16 20:12 Tx date 2020-05-11 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,553 vol |
2,868 | |
| Filed 2020-09-16 20:12 Tx date 2020-09-10 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+1,301 vol |
3,639 | |
| Filed 2020-09-16 20:11 Tx date 2020-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+681 vol |
2,338 | |
| Filed 2020-09-16 20:10 Tx date 2020-05-11 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
37 - Stock split or consolidation
|
-18,231 vol |
1,657 | |
| Filed 2020-09-16 20:09 Tx date 2020-09-10 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,582 vol |
13,785 | |
| Filed 2020-09-16 20:08 Tx date 2020-05-31 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,131 vol |
9,203 | |
| Filed 2020-09-16 20:07 Tx date 2020-05-11 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-76,786 vol |
7,072 | |
| Filed 2020-09-16 20:04 Tx date 2020-03-02 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,159 vol |
83,858 | |
| Filed 2020-03-06 23:16 Tx date 2020-03-02 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,466 vol |
||
| Filed 2020-05-21 19:33 Tx date 2020-05-20 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,510
+800 vol $5.64 each |
4,000 | |
| Filed 2020-04-02 17:38 Tx date 2020-03-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$104,645
+2,315,172 vol $0.0452 each |
2,915,172 | |
| Filed 2020-03-06 23:18 Tx date 2020-03-02 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+7,251 vol |
19,888 | |
| Filed 2020-03-06 23:16 Tx date 2020-03-02 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,466 vol |
75,165 | |
| Filed 2020-02-03 19:35 Tx date 2019-12-31 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
56 - Grant of rights
|
+4,721 vol |
4,721 | |
| Filed 2020-02-03 19:34 Tx date 2019-05-30 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Rights - Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-13 17:27 Tx date 2019-12-09 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,000
-10,000 vol $3.30 each |
34,421 | |
| Filed 2019-09-13 18:40 Tx date 2019-09-10 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+6,637 vol |
12,637 | |
| Filed 2019-09-13 18:40 Tx date 2019-09-10 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,699 vol |
61,699 | |
| Filed 2019-08-09 16:01 Tx date 2019-08-08 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,860
+40,500 vol $0.12 each |
129,000 | |
| Filed 2019-07-17 17:40 Tx date 2019-04-22 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-100,256
-8,320 vol $12.05 each |
44,421 | |
| Filed 2019-06-03 12:17 Tx date 2019-05-30 |
$EXE
Extendicare Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,200 | ||
| Filed 2019-03-07 Tx date 2019-03-06 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,000
+200,000 vol $0.13 each |
600,000 | |
| Filed 2019-01-31 Tx date 2019-01-28 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-31 Tx date 2019-01-28 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
150,000 | |
| Filed 2018-12-28 Tx date 2018-12-27 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,135
+28,500 vol $0.11 each |
88,500 | |
| Filed 2018-12-05 Tx date 2018-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
$45,060
+6,000 vol $7.51 each |
6,000 | |
| Filed 2018-12-05 Tx date 2018-07-25 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-05 Tx date 2018-11-30 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$262,850
+35,000 vol $7.51 each |
35,000 | |
| Filed 2018-12-05 Tx date 2018-07-25 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-28 Tx date 2018-08-28 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,600
+20,000 vol $0.28 each |
60,000 | |
| Filed 2018-07-26 Tx date 2018-07-25 |
$ACB
Aurora Cannabis Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
52,741 | ||
| Filed 2018-07-07 Tx date 2018-06-29 |
$LEAF
MedReleaf Corp. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit (DSU)
56 - Grant of rights
|
$140,004
+5,119 vol $27.35 each |
15,645 | |
| Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2018-03-21 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
300,000 | |
| Filed 2017-06-13 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit (DSU)
00 - Opening Balance-Initial SEDI Report
|
10,526 | ||
| Filed 2017-06-09 Tx date 2017-06-08 |
$LEAF
MedReleaf Corp. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$22,203
+2,600 vol $8.54 each |
2,600 | |
| Filed 2017-06-08 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-08 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-04 Tx date 2016-11-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,550
+15,000 vol $0.17 each |
40,000 | |
| Filed 2016-08-12 Tx date 2015-06-26 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-12 Tx date 2016-08-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,250
+25,000 vol $0.09 each |
25,000 | |
| Filed 2016-03-08 Tx date 2016-03-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2016-03-08 Tx date 2015-06-26 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|